Thomas Scheidmeir
Amministratore Delegato presso AbbVie Deutschland GmbH & Co. KG
Posizioni attive di Thomas Scheidmeir
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
AbbVie Deutschland GmbH & Co. KG
 AbbVie Deutschland GmbH & Co. KG BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Deutschland GmbH & Co. KG is a German company that focuses on treating plaque psoriasis, a chronic inflammatory skin disease that cannot be cured but can be managed effectively. The company is based in Wiesbaden, Germany. The CEOs of the company are Thomas Scheidmeir, Stefan Simianer. | Amministratore Delegato | - | - |
AbbVie Pharmaceuticals GmbH
 AbbVie Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Pharmaceuticals GmbH is a German pharmaceutical company that manufactures pharmaceuticals. The company is based in Hannover, Germany. The CEO of the company is Patrick Horber. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Thomas Scheidmeir
Statistiche
Distribuzione geografica
| Germania | 3 |
Posizioni
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
AbbVie Deutschland GmbH & Co. KG
AbbVie Deutschland GmbH & Co. KG BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Deutschland GmbH & Co. KG is a German company that focuses on treating plaque psoriasis, a chronic inflammatory skin disease that cannot be cured but can be managed effectively. The company is based in Wiesbaden, Germany. The CEOs of the company are Thomas Scheidmeir, Stefan Simianer. | Health Technology |
AbbVie Pharmaceuticals GmbH
AbbVie Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Pharmaceuticals GmbH is a German pharmaceutical company that manufactures pharmaceuticals. The company is based in Hannover, Germany. The CEO of the company is Patrick Horber. | Health Technology |
- Borsa valori
- Insiders
- Thomas Scheidmeir
- Esperienza
